The company operates in three primary segments: trading agricultural commodities, manufacturing and selling feminine hygiene products like sanitary napkins, and managing an e-commerce platform for grocery and household essentials.
The company operates in highly commoditized markets with no evidence of pricing power, as net margins are extremely thin at 1.2%. While management claims a unique women-led distribution network, the financial results show declining revenues and poor returns on capital, contradicting the existence of a durable competitive advantage.
Management has prioritized equity expansion through rights and bonus issues to fund working capital and repay debt. However, the incremental capital has not translated into earnings growth, with EPS declining significantly and ROCE remaining below the cost of capital.
The business collapsed as the inability to verify inventory and trade balances masked a hollow core. The massive outstanding tax liabilities and statutory defaults eventually triggered aggressive regulatory enforcement, freezing operations. Without any pricing power in a commoditized market, the razor-thin margins turned into permanent losses as revenue continued its steep decline, and the unutilized rights issue proceeds were eventually dissipated on overhead rather than productive growth.
RichFakir rates Times Green Energy India Ltd's business quality as poor — 28/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Times Green Energy India Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Times Green Energy India Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Times Green Energy India Ltd's fair value is about ₹7 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →